

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 6.46911360 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 6.46911360 |
| 3 | triglyceride catabolic process (GO:0019433) | 6.13534757 |
| 4 | low-density lipoprotein particle clearance (GO:0034383) | 5.66609841 |
| 5 | endocrine pancreas development (GO:0031018) | 5.55040739 |
| 6 | type B pancreatic cell development (GO:0003323) | 5.44758380 |
| 7 | neutral lipid catabolic process (GO:0046461) | 5.44179186 |
| 8 | acylglycerol catabolic process (GO:0046464) | 5.44179186 |
| 9 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.99124837 |
| 10 | regulation of sequestering of triglyceride (GO:0010889) | 4.91214011 |
| 11 | protein maturation by protein folding (GO:0022417) | 4.81239334 |
| 12 | transcytosis (GO:0045056) | 4.73681783 |
| 13 | protein heterotrimerization (GO:0070208) | 4.72868495 |
| 14 | insulin secretion (GO:0030073) | 4.71975488 |
| 15 | peptide hormone processing (GO:0016486) | 4.66365132 |
| 16 | glandular epithelial cell development (GO:0002068) | 4.59138096 |
| 17 | response to dietary excess (GO:0002021) | 4.29223820 |
| 18 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.27301793 |
| 19 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.25952957 |
| 20 | protein retention in ER lumen (GO:0006621) | 4.20279343 |
| 21 | glandular epithelial cell differentiation (GO:0002067) | 4.20124639 |
| 22 | ethanol oxidation (GO:0006069) | 4.14531430 |
| 23 | detection of calcium ion (GO:0005513) | 4.07441119 |
| 24 | cerebellar Purkinje cell layer development (GO:0021680) | 3.96835378 |
| 25 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.95316831 |
| 26 | regulation of gonadotropin secretion (GO:0032276) | 3.94331488 |
| 27 | glycerolipid catabolic process (GO:0046503) | 3.94009276 |
| 28 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.93407701 |
| 29 | cellular response to vitamin (GO:0071295) | 3.91059358 |
| 30 | positive regulation of insulin secretion (GO:0032024) | 3.87020144 |
| 31 | extracellular fibril organization (GO:0043206) | 3.83169474 |
| 32 | COPII vesicle coating (GO:0048208) | 3.80423692 |
| 33 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.74143004 |
| 34 | fatty acid homeostasis (GO:0055089) | 3.69262674 |
| 35 | * regulation of insulin secretion (GO:0050796) | 3.68486583 |
| 36 | positive regulation of nuclease activity (GO:0032075) | 3.67871370 |
| 37 | ER overload response (GO:0006983) | 3.66453480 |
| 38 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.65743142 |
| 39 | ovulation from ovarian follicle (GO:0001542) | 3.63918560 |
| 40 | nitric oxide mediated signal transduction (GO:0007263) | 3.63704492 |
| 41 | glomerular filtration (GO:0003094) | 3.59852318 |
| 42 | peptide hormone secretion (GO:0030072) | 3.53713625 |
| 43 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.52205419 |
| 44 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.51606377 |
| 45 | ethanol metabolic process (GO:0006067) | 3.48212960 |
| 46 | peptide secretion (GO:0002790) | 3.48154056 |
| 47 | primary alcohol catabolic process (GO:0034310) | 3.47436984 |
| 48 | positive regulation of glycolytic process (GO:0045821) | 3.46355088 |
| 49 | protein targeting to Golgi (GO:0000042) | 3.44390295 |
| 50 | cellular response to leptin stimulus (GO:0044320) | 3.44266048 |
| 51 | white fat cell differentiation (GO:0050872) | 3.42096153 |
| 52 | cellular response to vitamin D (GO:0071305) | 3.40828411 |
| 53 | protein localization to cell surface (GO:0034394) | 3.38637957 |
| 54 | exocrine pancreas development (GO:0031017) | 3.37206057 |
| 55 | * regulation of peptide hormone secretion (GO:0090276) | 3.35198304 |
| 56 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.34929135 |
| 57 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.33971008 |
| 58 | regulation of nuclease activity (GO:0032069) | 3.32692412 |
| 59 | cell migration involved in heart development (GO:0060973) | 3.32074342 |
| 60 | * regulation of peptide secretion (GO:0002791) | 3.31114455 |
| 61 | lipid particle organization (GO:0034389) | 3.28447544 |
| 62 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.27656979 |
| 63 | sequestering of metal ion (GO:0051238) | 3.27458238 |
| 64 | vesicle coating (GO:0006901) | 3.24749106 |
| 65 | polyol transport (GO:0015791) | 3.24573810 |
| 66 | barbed-end actin filament capping (GO:0051016) | 3.24561592 |
| 67 | lipid storage (GO:0019915) | 3.24164923 |
| 68 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.23325897 |
| 69 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.23277881 |
| 70 | regulation of lipoprotein metabolic process (GO:0050746) | 3.22895419 |
| 71 | synaptic vesicle maturation (GO:0016188) | 3.21766689 |
| 72 | negative regulation of response to food (GO:0032096) | 3.20359814 |
| 73 | negative regulation of appetite (GO:0032099) | 3.20359814 |
| 74 | fibril organization (GO:0097435) | 3.15966270 |
| 75 | positive regulation of peptide hormone secretion (GO:0090277) | 3.15427099 |
| 76 | cellular response to unfolded protein (GO:0034620) | 3.14838481 |
| 77 | response to leptin (GO:0044321) | 3.14229619 |
| 78 | inner ear receptor cell development (GO:0060119) | 3.13450491 |
| 79 | membrane repolarization during action potential (GO:0086011) | 3.11822509 |
| 80 | negative regulation of gluconeogenesis (GO:0045721) | 3.11132409 |
| 81 | positive regulation of peptide secretion (GO:0002793) | 3.10344381 |
| 82 | diacylglycerol metabolic process (GO:0046339) | 3.10232543 |
| 83 | renal filtration (GO:0097205) | 3.08547064 |
| 84 | chemosensory behavior (GO:0007635) | 3.05794001 |
| 85 | cGMP-mediated signaling (GO:0019934) | 3.05543265 |
| 86 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.04716663 |
| 87 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.04261509 |
| 88 | ER-nucleus signaling pathway (GO:0006984) | 3.04022636 |
| 89 | primary alcohol metabolic process (GO:0034308) | 3.00891614 |
| 90 | establishment of protein localization to Golgi (GO:0072600) | 3.00606833 |
| 91 | negative regulation of amino acid transport (GO:0051956) | 3.00083610 |
| 92 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.99591365 |
| 93 | cellular response to topologically incorrect protein (GO:0035967) | 2.98764831 |
| 94 | negative regulation of macrophage differentiation (GO:0045650) | 2.98510541 |
| 95 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.98451171 |
| 96 | macroautophagy (GO:0016236) | 2.98151910 |
| 97 | signal peptide processing (GO:0006465) | 2.97994061 |
| 98 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.97372678 |
| 99 | regulation of beta-amyloid formation (GO:1902003) | 2.97254218 |
| 100 | positive regulation of glomerulus development (GO:0090193) | 2.97228341 |
| 101 | astrocyte differentiation (GO:0048708) | 2.93568802 |
| 102 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.93336595 |
| 103 | cellular response to glucagon stimulus (GO:0071377) | 2.92797780 |
| 104 | relaxation of cardiac muscle (GO:0055119) | 2.92776872 |
| 105 | cellular response to epinephrine stimulus (GO:0071872) | 2.92148062 |
| 106 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.91571266 |
| 107 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.91126098 |
| 108 | * regulation of hormone secretion (GO:0046883) | 2.87629349 |
| 109 | negative regulation of bone resorption (GO:0045779) | 2.82540395 |
| 110 | proline transport (GO:0015824) | 2.81051269 |
| 111 | activation of protein kinase A activity (GO:0034199) | 2.80945850 |
| 112 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.80888591 |
| 113 | retinol metabolic process (GO:0042572) | 2.80446172 |
| 114 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.79990922 |
| 115 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.79783338 |
| 116 | peptide transport (GO:0015833) | 2.79279226 |
| 117 | suckling behavior (GO:0001967) | 2.76559797 |
| 118 | epithelial cell fate commitment (GO:0072148) | 2.75508408 |
| 119 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.75449227 |
| 120 | cell communication by electrical coupling (GO:0010644) | 2.72824208 |
| 121 | positive regulation of metanephros development (GO:0072216) | 2.71854612 |
| 122 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.71337835 |
| 123 | NADH metabolic process (GO:0006734) | 2.70367517 |
| 124 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.69945090 |
| 125 | * regulation of peptide transport (GO:0090087) | 2.69437847 |
| 126 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.69047397 |
| 127 | alanine transport (GO:0032328) | 2.68388808 |
| 128 | response to endoplasmic reticulum stress (GO:0034976) | 2.68285808 |
| 129 | triglyceride biosynthetic process (GO:0019432) | 2.68135031 |
| 130 | eosinophil chemotaxis (GO:0048245) | 2.68045593 |
| 131 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.68006190 |
| 132 | negative regulation of granulocyte differentiation (GO:0030853) | 2.66906650 |
| 133 | hormone secretion (GO:0046879) | 2.66838746 |
| 134 | positive regulation of fatty acid oxidation (GO:0046321) | 2.66554016 |
| 135 | positive regulation of receptor recycling (GO:0001921) | 2.66407401 |
| 136 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.66250425 |
| 137 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.65792730 |
| 138 | keratan sulfate catabolic process (GO:0042340) | 2.64818886 |
| 139 | * regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.64407583 |
| 140 | protein localization to Golgi apparatus (GO:0034067) | 2.64096851 |
| 141 | locomotory exploration behavior (GO:0035641) | 2.63948468 |
| 142 | positive regulation of glucose import (GO:0046326) | 2.62495011 |
| 143 | triglyceride metabolic process (GO:0006641) | 2.62463846 |
| 144 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.61781766 |
| 145 | potassium ion import (GO:0010107) | 2.61144765 |
| 146 | nucleoside diphosphate catabolic process (GO:0009134) | 2.60535787 |
| 147 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.60083123 |
| 148 | synaptic vesicle exocytosis (GO:0016079) | 2.58758938 |
| 149 | regulation of synaptic vesicle transport (GO:1902803) | 2.58358056 |
| 150 | negative regulation of metanephros development (GO:0072217) | 2.57082152 |
| 151 | regulation of glucocorticoid secretion (GO:2000849) | 2.56317112 |
| 152 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.56203284 |
| 153 | acylglycerol biosynthetic process (GO:0046463) | 2.56045903 |
| 154 | neutral lipid biosynthetic process (GO:0046460) | 2.56045903 |
| 155 | toxin metabolic process (GO:0009404) | 2.55328364 |
| 156 | brown fat cell differentiation (GO:0050873) | 2.54719974 |
| 157 | negative regulation of cartilage development (GO:0061037) | 2.54581051 |
| 158 | negative regulation of tissue remodeling (GO:0034104) | 2.54333374 |
| 159 | extracellular matrix assembly (GO:0085029) | 2.54276629 |
| 160 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.52320625 |
| 161 | phosphatidic acid biosynthetic process (GO:0006654) | 2.52003606 |
| 162 | phosphatidic acid metabolic process (GO:0046473) | 2.52003606 |
| 163 | innervation (GO:0060384) | 2.51864119 |
| 164 | cellular potassium ion homeostasis (GO:0030007) | 2.51841881 |
| 165 | signal release (GO:0023061) | 2.49398973 |
| 166 | pancreas development (GO:0031016) | 2.49263070 |
| 167 | somite development (GO:0061053) | 2.49028516 |
| 168 | hormone transport (GO:0009914) | 2.49010122 |
| 169 | induction of positive chemotaxis (GO:0050930) | 2.48604503 |
| 170 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.48319379 |
| 171 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.47933314 |
| 172 | positive regulation of hormone secretion (GO:0046887) | 2.47878383 |
| 173 | response to unfolded protein (GO:0006986) | 2.47452729 |
| 174 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.47230193 |
| 175 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.45204907 |
| 176 | angiogenesis involved in wound healing (GO:0060055) | 2.44879779 |
| 177 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.44644649 |
| 178 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.43964878 |
| 179 | sodium ion export (GO:0071436) | 2.43870135 |
| 180 | response to epinephrine (GO:0071871) | 2.43532234 |
| 181 | metanephric mesenchyme development (GO:0072075) | 2.43178468 |
| 182 | adult feeding behavior (GO:0008343) | 2.41040347 |
| 183 | positive regulation of vasculogenesis (GO:2001214) | 2.40881667 |
| 184 | short-term memory (GO:0007614) | 2.40739779 |
| 185 | negative regulation of protein autophosphorylation (GO:0031953) | 2.39617426 |
| 186 | acylglycerol metabolic process (GO:0006639) | 2.39400389 |
| 187 | neutral lipid metabolic process (GO:0006638) | 2.39237615 |
| 188 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.38795618 |
| 189 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.38528499 |
| 190 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.36297660 |
| 191 | polyketide metabolic process (GO:0030638) | 2.36064665 |
| 192 | doxorubicin metabolic process (GO:0044598) | 2.36064665 |
| 193 | daunorubicin metabolic process (GO:0044597) | 2.36064665 |
| 194 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.35062433 |
| 195 | response to vitamin E (GO:0033197) | 2.31123598 |
| 196 | positive regulation of glucose transport (GO:0010828) | 2.30700550 |
| 197 | glycerol metabolic process (GO:0006071) | 2.30696438 |
| 198 | endothelium development (GO:0003158) | 2.28871442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.72074402 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.49623963 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.85225135 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.49543268 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.44625742 |
| 6 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35639538 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.34027412 |
| 8 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25266818 |
| 9 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.14717616 |
| 10 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.12888922 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.10604488 |
| 12 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.09948095 |
| 13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.07906576 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.06518406 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.98765080 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.98459138 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.97188328 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95144685 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.94863103 |
| 20 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94257385 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.93746979 |
| 22 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.90289631 |
| 23 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.84784640 |
| 24 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.84784640 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.84390898 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83250718 |
| 27 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.76715948 |
| 28 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.72819660 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71457698 |
| 30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.60638210 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57048427 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.54154031 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52919087 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52251190 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42360754 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42189300 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42012253 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41602076 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41064174 |
| 40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.40525839 |
| 41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.40495221 |
| 42 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39622398 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.36844145 |
| 44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36679637 |
| 45 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.35307753 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.31629963 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.31629963 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29039903 |
| 49 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.27960329 |
| 50 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26999277 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25784452 |
| 52 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23926148 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23888446 |
| 54 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23437230 |
| 55 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.22366184 |
| 56 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22173785 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21844206 |
| 58 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21485110 |
| 59 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19778349 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19149206 |
| 61 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18071642 |
| 62 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17481477 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16044667 |
| 64 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15860370 |
| 65 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.15452374 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15144193 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14976443 |
| 68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13597747 |
| 69 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13226328 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12477802 |
| 71 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12474050 |
| 72 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10503655 |
| 73 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10461803 |
| 74 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08816968 |
| 75 | AR_19668381_ChIP-Seq_PC3_Human | 1.07656264 |
| 76 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07656216 |
| 77 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07595341 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07117182 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05592383 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.04858688 |
| 81 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04857203 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04281407 |
| 83 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03803492 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01521885 |
| 85 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.01218108 |
| 86 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01196229 |
| 87 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99114954 |
| 88 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99073350 |
| 89 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98760219 |
| 90 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98589386 |
| 91 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97923546 |
| 92 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97069303 |
| 93 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.96543333 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96253556 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95726101 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95322488 |
| 97 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.95295100 |
| 98 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95009770 |
| 99 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.94769686 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94768509 |
| 101 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94711568 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94680935 |
| 103 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94664127 |
| 104 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94368967 |
| 105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93957957 |
| 106 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93236948 |
| 107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92942506 |
| 108 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.91255756 |
| 109 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.91209297 |
| 110 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.91007456 |
| 111 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90953589 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90518211 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89423668 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89376260 |
| 115 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89376260 |
| 116 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89176568 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88265707 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88009527 |
| 119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87521010 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87296546 |
| 121 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.86573859 |
| 122 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86238331 |
| 123 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84485049 |
| 124 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83973888 |
| 125 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83876353 |
| 126 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.83653317 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83370582 |
| 128 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83171391 |
| 129 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.83022716 |
| 130 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.82806062 |
| 131 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.82631627 |
| 132 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80944778 |
| 133 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.80751403 |
| 134 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.80711901 |
| 135 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80246219 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80189559 |
| 137 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80188011 |
| 138 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80095636 |
| 139 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79892431 |
| 140 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78807896 |
| 141 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.78806086 |
| 142 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78480188 |
| 143 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.78164128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 5.84151444 |
| 2 | MP0005670_abnormal_white_adipose | 5.64778328 |
| 3 | MP0002909_abnormal_adrenal_gland | 4.14372492 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 4.09764718 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.91010278 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 3.90435533 |
| 7 | MP0004043_abnormal_pH_regulation | 3.84083303 |
| 8 | MP0005666_abnormal_adipose_tissue | 3.83380118 |
| 9 | MP0002693_abnormal_pancreas_physiology | 3.46190882 |
| 10 | MP0005275_abnormal_skin_tensile | 3.42426264 |
| 11 | MP0010386_abnormal_urinary_bladder | 3.19110565 |
| 12 | MP0001944_abnormal_pancreas_morphology | 3.10085346 |
| 13 | MP0004130_abnormal_muscle_cell | 3.02159402 |
| 14 | MP0002971_abnormal_brown_adipose | 3.01587470 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.86096215 |
| 16 | MP0000678_abnormal_parathyroid_gland | 2.77782111 |
| 17 | MP0004270_analgesia | 2.67769053 |
| 18 | MP0005379_endocrine/exocrine_gland_phen | 2.47126174 |
| 19 | MP0003279_aneurysm | 2.29323487 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.10733190 |
| 21 | MP0001986_abnormal_taste_sensitivity | 2.09297486 |
| 22 | MP0009115_abnormal_fat_cell | 2.03030773 |
| 23 | MP0002108_abnormal_muscle_morphology | 2.02538609 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 2.01407893 |
| 25 | MP0002295_abnormal_pulmonary_circulatio | 1.99607660 |
| 26 | MP0003195_calcinosis | 1.98845235 |
| 27 | MP0004272_abnormal_basement_membrane | 1.96062686 |
| 28 | MP0004859_abnormal_synaptic_plasticity | 1.91475540 |
| 29 | MP0006072_abnormal_retinal_apoptosis | 1.86156478 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.83753832 |
| 31 | MP0000462_abnormal_digestive_system | 1.82369110 |
| 32 | * MP0002078_abnormal_glucose_homeostasis | 1.81184653 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.80628702 |
| 34 | * MP0003635_abnormal_synaptic_transmissio | 1.78397533 |
| 35 | MP0006138_congestive_heart_failure | 1.76964919 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.74603907 |
| 37 | MP0005220_abnormal_exocrine_pancreas | 1.73814161 |
| 38 | MP0002970_abnormal_white_adipose | 1.71136413 |
| 39 | MP0003186_abnormal_redox_activity | 1.69578457 |
| 40 | MP0003724_increased_susceptibility_to | 1.68948643 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.68196373 |
| 42 | MP0002822_catalepsy | 1.67195923 |
| 43 | MP0003122_maternal_imprinting | 1.66578373 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.66083658 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.65488000 |
| 46 | MP0004858_abnormal_nervous_system | 1.63806348 |
| 47 | MP0009384_cardiac_valve_regurgitation | 1.62664229 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.62007302 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.61292569 |
| 50 | MP0003011_delayed_dark_adaptation | 1.59691174 |
| 51 | MP0005334_abnormal_fat_pad | 1.57689530 |
| 52 | MP0002896_abnormal_bone_mineralization | 1.53633471 |
| 53 | MP0001879_abnormal_lymphatic_vessel | 1.53349055 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.51683380 |
| 55 | MP0001765_abnormal_ion_homeostasis | 1.49992494 |
| 56 | MP0002234_abnormal_pharynx_morphology | 1.47912143 |
| 57 | MP0005423_abnormal_somatic_nervous | 1.46601647 |
| 58 | MP0000751_myopathy | 1.43704728 |
| 59 | MP0000003_abnormal_adipose_tissue | 1.41365317 |
| 60 | MP0003868_abnormal_feces_composition | 1.40249693 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.40197823 |
| 62 | MP0001958_emphysema | 1.40049018 |
| 63 | MP0000613_abnormal_salivary_gland | 1.38080540 |
| 64 | MP0002733_abnormal_thermal_nociception | 1.33904990 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.32000808 |
| 66 | MP0005508_abnormal_skeleton_morphology | 1.31631530 |
| 67 | MP0008961_abnormal_basal_metabolism | 1.30230405 |
| 68 | MP0003879_abnormal_hair_cell | 1.29144219 |
| 69 | MP0003828_pulmonary_edema | 1.28784452 |
| 70 | MP0001501_abnormal_sleep_pattern | 1.28516076 |
| 71 | MP0002063_abnormal_learning/memory/cond | 1.28394112 |
| 72 | MP0002572_abnormal_emotion/affect_behav | 1.26778096 |
| 73 | MP0005503_abnormal_tendon_morphology | 1.26489719 |
| 74 | MP0002876_abnormal_thyroid_physiology | 1.23827717 |
| 75 | MP0003953_abnormal_hormone_level | 1.19660299 |
| 76 | MP0010368_abnormal_lymphatic_system | 1.19103787 |
| 77 | MP0001299_abnormal_eye_distance/ | 1.18990334 |
| 78 | MP0005595_abnormal_vascular_smooth | 1.18723763 |
| 79 | MP0009745_abnormal_behavioral_response | 1.17997296 |
| 80 | MP0003880_abnormal_central_pattern | 1.16446228 |
| 81 | MP0001348_abnormal_lacrimal_gland | 1.16018203 |
| 82 | MP0003690_abnormal_glial_cell | 1.15300211 |
| 83 | MP0001970_abnormal_pain_threshold | 1.13968687 |
| 84 | MP0002064_seizures | 1.13598837 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 1.09510014 |
| 86 | MP0000372_irregular_coat_pigmentation | 1.08603798 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 1.06083856 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 1.05330960 |
| 89 | MP0005452_abnormal_adipose_tissue | 1.04397379 |
| 90 | MP0003172_abnormal_lysosome_physiology | 1.04315697 |
| 91 | MP0006054_spinal_hemorrhage | 1.04158343 |
| 92 | MP0005535_abnormal_body_temperature | 1.03766818 |
| 93 | MP0002557_abnormal_social/conspecific_i | 1.02418249 |
| 94 | MP0006276_abnormal_autonomic_nervous | 1.01367050 |
| 95 | MP0002272_abnormal_nervous_system | 1.01308537 |
| 96 | MP0001440_abnormal_grooming_behavior | 1.00922875 |
| 97 | MP0000955_abnormal_spinal_cord | 1.00847188 |
| 98 | MP0004885_abnormal_endolymph | 1.00392068 |
| 99 | MP0002933_joint_inflammation | 1.00017587 |
| 100 | MP0005409_darkened_coat_color | 0.99899047 |
| 101 | MP0003329_amyloid_beta_deposits | 0.98684281 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.96518548 |
| 103 | MP0005058_abnormal_lysosome_morphology | 0.96503330 |
| 104 | MP0003950_abnormal_plasma_membrane | 0.96446466 |
| 105 | MP0000249_abnormal_blood_vessel | 0.95944469 |
| 106 | MP0000343_altered_response_to | 0.95937711 |
| 107 | MP0005310_abnormal_salivary_gland | 0.94840499 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.94034085 |
| 109 | MP0005171_absent_coat_pigmentation | 0.93292639 |
| 110 | MP0003866_abnormal_defecation | 0.91667822 |
| 111 | MP0001270_distended_abdomen | 0.91031294 |
| 112 | MP0003633_abnormal_nervous_system | 0.90349228 |
| 113 | MP0000538_abnormal_urinary_bladder | 0.89140871 |
| 114 | MP0003634_abnormal_glial_cell | 0.87869587 |
| 115 | MP0005164_abnormal_response_to | 0.87646263 |
| 116 | MP0001502_abnormal_circadian_rhythm | 0.86347452 |
| 117 | MP0005385_cardiovascular_system_phenoty | 0.84953542 |
| 118 | MP0001544_abnormal_cardiovascular_syste | 0.84953542 |
| 119 | MP0003787_abnormal_imprinting | 0.84045957 |
| 120 | MP0002928_abnormal_bile_duct | 0.83234069 |
| 121 | MP0002102_abnormal_ear_morphology | 0.82359931 |
| 122 | MP0005187_abnormal_penis_morphology | 0.81878849 |
| 123 | MP0002067_abnormal_sensory_capabilities | 0.80691174 |
| 124 | MP0005253_abnormal_eye_physiology | 0.80233712 |
| 125 | MP0005165_increased_susceptibility_to | 0.79896265 |
| 126 | MP0002069_abnormal_eating/drinking_beha | 0.79650669 |
| 127 | MP0003045_fibrosis | 0.79351292 |
| 128 | MP0004924_abnormal_behavior | 0.79119714 |
| 129 | MP0005386_behavior/neurological_phenoty | 0.79119714 |
| 130 | MP0001664_abnormal_digestion | 0.78282485 |
| 131 | MP0001542_abnormal_bone_strength | 0.78150799 |
| 132 | MP0003959_abnormal_lean_body | 0.77711412 |
| 133 | MP0008569_lethality_at_weaning | 0.77269681 |
| 134 | MP0000566_synostosis | 0.76547696 |
| 135 | MP0001968_abnormal_touch/_nociception | 0.75423603 |
| 136 | MP0002133_abnormal_respiratory_system | 0.75253438 |
| 137 | MP0005388_respiratory_system_phenotype | 0.75253438 |
| 138 | MP0001177_atelectasis | 0.74986916 |
| 139 | MP0004215_abnormal_myocardial_fiber | 0.73120443 |
| 140 | MP0001661_extended_life_span | 0.72957257 |
| 141 | MP0009672_abnormal_birth_weight | 0.70560530 |
| 142 | MP0009250_abnormal_appendicular_skeleto | 0.69761851 |
| 143 | MP0000759_abnormal_skeletal_muscle | 0.69048638 |
| 144 | MP0001984_abnormal_olfaction | 0.68361932 |
| 145 | MP0002249_abnormal_larynx_morphology | 0.67650687 |
| 146 | MP0002115_abnormal_skeleton_extremities | 0.67019232 |
| 147 | MP0005375_adipose_tissue_phenotype | 0.66548030 |
| 148 | MP0009643_abnormal_urine_homeostasis | 0.66494313 |
| 149 | MP0002066_abnormal_motor_capabilities/c | 0.66005210 |
| 150 | MP0009703_decreased_birth_body | 0.65595249 |
| 151 | MP0005448_abnormal_energy_balance | 0.65506673 |
| 152 | MP0005647_abnormal_sex_gland | 0.65479475 |
| 153 | MP0003948_abnormal_gas_homeostasis | 0.65303565 |
| 154 | MP0001486_abnormal_startle_reflex | 0.65210118 |
| 155 | MP0001756_abnormal_urination | 0.65153928 |
| 156 | MP0002229_neurodegeneration | 0.64938901 |
| 157 | MP0000163_abnormal_cartilage_morphology | 0.64825571 |
| 158 | * MP0000230_abnormal_systemic_arterial | 0.64708869 |
| 159 | MP0002090_abnormal_vision | 0.64062854 |
| 160 | MP0005390_skeleton_phenotype | 0.61151212 |
| 161 | MP0008004_abnormal_stomach_pH | 0.57500459 |
| 162 | MP0002735_abnormal_chemical_nociception | 0.56464142 |
| 163 | MP0000534_abnormal_ureter_morphology | 0.56179511 |
| 164 | MP0003075_altered_response_to | 0.56138606 |
| 165 | MP0002128_abnormal_blood_circulation | 0.54827958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.19388271 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.62729112 |
| 3 | Hypoglycemic seizures (HP:0002173) | 5.75393617 |
| 4 | Protrusio acetabuli (HP:0003179) | 5.56427007 |
| 5 | Symptomatic seizures (HP:0011145) | 5.43299735 |
| 6 | Oligomenorrhea (HP:0000876) | 4.92179173 |
| 7 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.76303624 |
| 8 | Acanthosis nigricans (HP:0000956) | 4.54774654 |
| 9 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.39947925 |
| 10 | Large for gestational age (HP:0001520) | 4.23073408 |
| 11 | Hypoglycemic coma (HP:0001325) | 4.18337573 |
| 12 | Decreased circulating renin level (HP:0003351) | 4.15986335 |
| 13 | Hyperglycemia (HP:0003074) | 4.01611904 |
| 14 | Aortic aneurysm (HP:0004942) | 3.96254672 |
| 15 | Broad metatarsal (HP:0001783) | 3.88601069 |
| 16 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.83618161 |
| 17 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.83618161 |
| 18 | Vascular tortuosity (HP:0004948) | 3.71445794 |
| 19 | Hypertriglyceridemia (HP:0002155) | 3.66528541 |
| 20 | Ketoacidosis (HP:0001993) | 3.66204964 |
| 21 | Late onset (HP:0003584) | 3.55058660 |
| 22 | Agitation (HP:0000713) | 3.53485458 |
| 23 | Hyperparathyroidism (HP:0000843) | 3.51087416 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.48284546 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.48284546 |
| 26 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.44383445 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 3.40627571 |
| 28 | Hypokalemia (HP:0002900) | 3.35129883 |
| 29 | Dysostosis multiplex (HP:0000943) | 3.34582619 |
| 30 | Papilledema (HP:0001085) | 3.24564730 |
| 31 | Premature rupture of membranes (HP:0001788) | 3.20369768 |
| 32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.18789621 |
| 33 | Soft skin (HP:0000977) | 3.12992989 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.08072290 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.08072290 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.08072290 |
| 37 | Abnormality of renin-angiotensin system (HP:0000847) | 3.06374432 |
| 38 | Arterial tortuosity (HP:0005116) | 3.03763557 |
| 39 | Abnormal pancreas size (HP:0012094) | 3.03723084 |
| 40 | Bone cyst (HP:0012062) | 2.91272897 |
| 41 | Spinal rigidity (HP:0003306) | 2.87647158 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.86966160 |
| 43 | EEG with generalized epileptiform discharges (HP:0011198) | 2.81116692 |
| 44 | Visual hallucinations (HP:0002367) | 2.78720223 |
| 45 | Abnormal eating behavior (HP:0100738) | 2.76692673 |
| 46 | Hypsarrhythmia (HP:0002521) | 2.76576142 |
| 47 | Lymphangioma (HP:0100764) | 2.74725207 |
| 48 | Hypercortisolism (HP:0001578) | 2.73299604 |
| 49 | Absent/shortened dynein arms (HP:0200106) | 2.72083672 |
| 50 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.72083672 |
| 51 | Epileptiform EEG discharges (HP:0011182) | 2.72029819 |
| 52 | Coronal craniosynostosis (HP:0004440) | 2.70385796 |
| 53 | Abnormality of potassium homeostasis (HP:0011042) | 2.69232749 |
| 54 | Shallow orbits (HP:0000586) | 2.68412529 |
| 55 | Overgrowth (HP:0001548) | 2.65278377 |
| 56 | Hyperkalemia (HP:0002153) | 2.63479203 |
| 57 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.63202200 |
| 58 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.63202200 |
| 59 | Polyphagia (HP:0002591) | 2.62087086 |
| 60 | Hyperactive renin-angiotensin system (HP:0000841) | 2.61473016 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.61094067 |
| 62 | Long foot (HP:0001833) | 2.61035024 |
| 63 | Hyperventilation (HP:0002883) | 2.59746947 |
| 64 | Aortic dissection (HP:0002647) | 2.59196636 |
| 65 | Retinal atrophy (HP:0001105) | 2.58911288 |
| 66 | Pheochromocytoma (HP:0002666) | 2.58046112 |
| 67 | Unilateral renal agenesis (HP:0000122) | 2.57971980 |
| 68 | Ankle contracture (HP:0006466) | 2.57312202 |
| 69 | Osteomalacia (HP:0002749) | 2.54397618 |
| 70 | Muscle fiber splitting (HP:0003555) | 2.53077540 |
| 71 | Abnormal ciliary motility (HP:0012262) | 2.52706254 |
| 72 | Increased circulating renin level (HP:0000848) | 2.49989512 |
| 73 | Striae distensae (HP:0001065) | 2.49619420 |
| 74 | Conjugated hyperbilirubinemia (HP:0002908) | 2.48771550 |
| 75 | Increased mean platelet volume (HP:0011877) | 2.47271871 |
| 76 | Vertebral compression fractures (HP:0002953) | 2.46544820 |
| 77 | Follicular hyperkeratosis (HP:0007502) | 2.46123474 |
| 78 | Supranuclear gaze palsy (HP:0000605) | 2.45980299 |
| 79 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.45235864 |
| 80 | Hypoplasia of the iris (HP:0007676) | 2.36634424 |
| 81 | Cervical subluxation (HP:0003308) | 2.36398008 |
| 82 | Prominent supraorbital ridges (HP:0000336) | 2.34881772 |
| 83 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.34700049 |
| 84 | Rhinitis (HP:0012384) | 2.34651319 |
| 85 | Growth hormone excess (HP:0000845) | 2.34116592 |
| 86 | Insulin resistance (HP:0000855) | 2.33033416 |
| 87 | Enlarged epiphyses (HP:0010580) | 2.32822291 |
| 88 | Wormian bones (HP:0002645) | 2.32185963 |
| 89 | Congenital glaucoma (HP:0001087) | 2.31484360 |
| 90 | Skin nodule (HP:0200036) | 2.27837253 |
| 91 | Epidermoid cyst (HP:0200040) | 2.25892161 |
| 92 | Complement deficiency (HP:0004431) | 2.24905065 |
| 93 | Ectopia lentis (HP:0001083) | 2.24568707 |
| 94 | Abnormality of the 1st metacarpal (HP:0010009) | 2.24143109 |
| 95 | Adrenal overactivity (HP:0002717) | 2.19638523 |
| 96 | Abnormality of the nasal mucosa (HP:0000433) | 2.19101141 |
| 97 | Abnormality of chloride homeostasis (HP:0011422) | 2.19000840 |
| 98 | Hyperphosphatemia (HP:0002905) | 2.18139893 |
| 99 | Neuroendocrine neoplasm (HP:0100634) | 2.17348736 |
| 100 | Hemorrhage of the eye (HP:0011885) | 2.17189736 |
| 101 | Chronic bronchitis (HP:0004469) | 2.16437487 |
| 102 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.16043852 |
| 103 | Cerebral inclusion bodies (HP:0100314) | 2.10093552 |
| 104 | Hypokalemic alkalosis (HP:0001949) | 2.09935460 |
| 105 | Neurofibrillary tangles (HP:0002185) | 2.09797136 |
| 106 | Abdominal distention (HP:0003270) | 2.09778907 |
| 107 | Prominent metopic ridge (HP:0005487) | 2.08977158 |
| 108 | Hemiparesis (HP:0001269) | 2.08330634 |
| 109 | Systemic lupus erythematosus (HP:0002725) | 2.07590427 |
| 110 | Abnormality of complement system (HP:0005339) | 2.07503530 |
| 111 | Coxa vara (HP:0002812) | 2.07428438 |
| 112 | Exocrine pancreatic insufficiency (HP:0001738) | 2.07310378 |
| 113 | Failure to thrive in infancy (HP:0001531) | 2.06237184 |
| 114 | Abnormal platelet volume (HP:0011876) | 2.06123565 |
| 115 | Atonic seizures (HP:0010819) | 2.05828342 |
| 116 | Polycythemia (HP:0001901) | 2.03441351 |
| 117 | Hypothermia (HP:0002045) | 2.01267759 |
| 118 | Bell-shaped thorax (HP:0001591) | 1.98689800 |
| 119 | Metaphyseal dysplasia (HP:0100255) | 1.98473224 |
| 120 | Hypotension (HP:0002615) | 1.97582005 |
| 121 | Restlessness (HP:0000711) | 1.96439732 |
| 122 | Venous insufficiency (HP:0005293) | 1.95711462 |
| 123 | Difficulty running (HP:0009046) | 1.95295016 |
| 124 | Ovoid vertebral bodies (HP:0003300) | 1.93736130 |
| 125 | Infantile muscular hypotonia (HP:0008947) | 1.92801451 |
| 126 | Ileus (HP:0002595) | 1.90273850 |
| 127 | Epileptic encephalopathy (HP:0200134) | 1.89600428 |
| 128 | Abnormality of the metopic suture (HP:0005556) | 1.87219772 |
| 129 | Vacuolated lymphocytes (HP:0001922) | 1.86717044 |
| 130 | Accelerated skeletal maturation (HP:0005616) | 1.85753050 |
| 131 | Generalized tonic-clonic seizures (HP:0002069) | 1.85710596 |
| 132 | Atelectasis (HP:0100750) | 1.85409177 |
| 133 | Pigmentary retinal degeneration (HP:0001146) | 1.85284304 |
| 134 | Dilatation of the ascending aorta (HP:0005111) | 1.85228699 |
| 135 | Macroorchidism (HP:0000053) | 1.85192225 |
| 136 | Venous abnormality (HP:0002624) | 1.83817409 |
| 137 | Stridor (HP:0010307) | 1.83602630 |
| 138 | Diplopia (HP:0000651) | 1.83558059 |
| 139 | Abnormality of binocular vision (HP:0011514) | 1.83558059 |
| 140 | Protuberant abdomen (HP:0001538) | 1.82339515 |
| 141 | Postural tremor (HP:0002174) | 1.82192194 |
| 142 | Hypophosphatemia (HP:0002148) | 1.82090908 |
| 143 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.81358621 |
| 144 | Genu recurvatum (HP:0002816) | 1.81172920 |
| 145 | Villous atrophy (HP:0011473) | 1.81035888 |
| 146 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.81035888 |
| 147 | Depression (HP:0000716) | 1.78674632 |
| 148 | Neoplasm of the heart (HP:0100544) | 1.77464859 |
| 149 | Hypoventilation (HP:0002791) | 1.76500660 |
| 150 | Conical tooth (HP:0000698) | 1.75630569 |
| 151 | Osteoarthritis (HP:0002758) | 1.75629491 |
| 152 | Xanthomatosis (HP:0000991) | 1.75610714 |
| 153 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.74872654 |
| 154 | Blue sclerae (HP:0000592) | 1.74748445 |
| 155 | Purpura (HP:0000979) | 1.74367065 |
| 156 | Bladder diverticulum (HP:0000015) | 1.74014668 |
| 157 | Megalencephaly (HP:0001355) | 1.73773663 |
| 158 | Hyperextensible skin (HP:0000974) | 1.73235007 |
| 159 | Type 1 muscle fiber predominance (HP:0003803) | 1.73028846 |
| 160 | Flared iliac wings (HP:0002869) | 1.72522397 |
| 161 | Cortical visual impairment (HP:0100704) | 1.72221041 |
| 162 | Torticollis (HP:0000473) | 1.72200600 |
| 163 | Aneurysm (HP:0002617) | 1.71242901 |
| 164 | Slender build (HP:0001533) | 1.71229277 |
| 165 | Severe short stature (HP:0003510) | 1.71216867 |
| 166 | Thoracolumbar scoliosis (HP:0002944) | 1.71205320 |
| 167 | Obstructive sleep apnea (HP:0002870) | 1.70413452 |
| 168 | Short 1st metacarpal (HP:0010034) | 1.70308134 |
| 169 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.70308134 |
| 170 | Hip contracture (HP:0003273) | 1.69709312 |
| 171 | Hypoplasia of the fovea (HP:0007750) | 1.69490825 |
| 172 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.69490825 |
| 173 | Bulbous nose (HP:0000414) | 1.69124563 |
| 174 | White forelock (HP:0002211) | 1.69054768 |
| 175 | Neonatal short-limb short stature (HP:0008921) | 1.68914563 |
| 176 | Hypoplasia of the odontoid process (HP:0003311) | 1.68556217 |
| 177 | Hyperphosphaturia (HP:0003109) | 1.68203969 |
| 178 | Hypocalcemia (HP:0002901) | 1.67992642 |
| 179 | Ventricular fibrillation (HP:0001663) | 1.67723920 |
| 180 | Spinal cord compression (HP:0002176) | 1.67002563 |
| 181 | Hyperaldosteronism (HP:0000859) | 1.65977443 |
| 182 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.65830558 |
| 183 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.64853760 |
| 184 | Anxiety (HP:0000739) | 1.63617825 |
| 185 | Prolonged QT interval (HP:0001657) | 1.63591137 |
| 186 | Absence seizures (HP:0002121) | 1.62693571 |
| 187 | Dysautonomia (HP:0002459) | 1.62340914 |
| 188 | Menstrual irregularities (HP:0000858) | 1.61112415 |
| 189 | Back pain (HP:0003418) | 1.60291179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.48364002 |
| 2 | PASK | 3.88963244 |
| 3 | TAOK3 | 3.74761273 |
| 4 | PRKD3 | 3.59842203 |
| 5 | EPHB2 | 3.58345713 |
| 6 | NTRK3 | 3.10518576 |
| 7 | IRAK3 | 3.05032300 |
| 8 | MAP3K2 | 3.00373236 |
| 9 | TGFBR2 | 2.78733985 |
| 10 | MYLK | 2.66688182 |
| 11 | HIPK2 | 2.51284959 |
| 12 | TIE1 | 2.50052608 |
| 13 | MAP3K1 | 2.46926397 |
| 14 | RIPK1 | 2.32184543 |
| 15 | MAPK15 | 2.14762396 |
| 16 | CAMKK2 | 2.13810679 |
| 17 | WNK4 | 2.13545930 |
| 18 | NTRK1 | 2.11210666 |
| 19 | FRK | 1.91217483 |
| 20 | LMTK2 | 1.89138170 |
| 21 | UHMK1 | 1.86130166 |
| 22 | LATS1 | 1.84139488 |
| 23 | PRKAA2 | 1.82105562 |
| 24 | TESK1 | 1.80372793 |
| 25 | MAP3K6 | 1.66432749 |
| 26 | ABL2 | 1.61630603 |
| 27 | CAMK1 | 1.59248014 |
| 28 | PRKCH | 1.52956775 |
| 29 | TRIB3 | 1.52401193 |
| 30 | MARK1 | 1.49553920 |
| 31 | ERN1 | 1.45822473 |
| 32 | CDC42BPA | 1.44108159 |
| 33 | PRKD2 | 1.42514468 |
| 34 | CAMKK1 | 1.40083469 |
| 35 | IRAK2 | 1.39533115 |
| 36 | LATS2 | 1.39404790 |
| 37 | NLK | 1.30636081 |
| 38 | SCYL2 | 1.30403909 |
| 39 | PDGFRA | 1.25527444 |
| 40 | MAP3K9 | 1.21286931 |
| 41 | IRAK1 | 1.17030228 |
| 42 | MAPK12 | 1.16445923 |
| 43 | GRK1 | 1.16060200 |
| 44 | KSR2 | 1.16006314 |
| 45 | RET | 1.15581208 |
| 46 | MINK1 | 1.12362924 |
| 47 | AKT3 | 1.12318967 |
| 48 | TNIK | 1.11653680 |
| 49 | ACVR1B | 1.10041940 |
| 50 | MAP2K2 | 1.09841480 |
| 51 | MAPK4 | 1.08190292 |
| 52 | RIPK4 | 1.03827551 |
| 53 | PAK3 | 1.03586665 |
| 54 | PTK2 | 1.03570448 |
| 55 | CAMK1G | 1.01720545 |
| 56 | PTK2B | 1.01315225 |
| 57 | MAP3K4 | 0.99249545 |
| 58 | KIT | 0.98082788 |
| 59 | GSK3A | 0.95149891 |
| 60 | MAPKAPK3 | 0.95010216 |
| 61 | BRAF | 0.94906905 |
| 62 | TRPM7 | 0.93154227 |
| 63 | PRKCE | 0.92929846 |
| 64 | EPHB1 | 0.91583846 |
| 65 | FGFR2 | 0.91204087 |
| 66 | GRK5 | 0.90392426 |
| 67 | CAMK2D | 0.89107729 |
| 68 | ROCK1 | 0.89027610 |
| 69 | WNK1 | 0.88414898 |
| 70 | STK38 | 0.83561871 |
| 71 | MAPK7 | 0.83470364 |
| 72 | PTK6 | 0.82996824 |
| 73 | SIK1 | 0.80054225 |
| 74 | CDK5 | 0.79937361 |
| 75 | DAPK3 | 0.78341479 |
| 76 | EPHA3 | 0.76613069 |
| 77 | RPS6KA2 | 0.76116688 |
| 78 | * ADRBK1 | 0.76067424 |
| 79 | PHKG2 | 0.72568227 |
| 80 | PHKG1 | 0.72568227 |
| 81 | SGK2 | 0.71851268 |
| 82 | NTRK2 | 0.69966795 |
| 83 | FLT3 | 0.69686491 |
| 84 | PNCK | 0.69404590 |
| 85 | MAP2K4 | 0.68411211 |
| 86 | DYRK1B | 0.68221877 |
| 87 | PAK6 | 0.68126496 |
| 88 | STK3 | 0.67870541 |
| 89 | PRKG1 | 0.67668743 |
| 90 | PDPK1 | 0.67122963 |
| 91 | TAOK1 | 0.67086049 |
| 92 | SIK2 | 0.66410497 |
| 93 | MET | 0.65932601 |
| 94 | ILK | 0.62623442 |
| 95 | PIK3CA | 0.62093176 |
| 96 | YES1 | 0.61931135 |
| 97 | CAMK2B | 0.61888701 |
| 98 | JAK2 | 0.59601458 |
| 99 | STK38L | 0.58548231 |
| 100 | GRK7 | 0.58170708 |
| 101 | DYRK2 | 0.58141531 |
| 102 | IRAK4 | 0.57931501 |
| 103 | CAMK2A | 0.57543799 |
| 104 | PRKD1 | 0.56251279 |
| 105 | MAPK13 | 0.56017578 |
| 106 | PRKCI | 0.54448116 |
| 107 | FER | 0.54428871 |
| 108 | MARK2 | 0.54224354 |
| 109 | ADRBK2 | 0.52932454 |
| 110 | ROCK2 | 0.52612975 |
| 111 | ALK | 0.52348001 |
| 112 | MAP2K1 | 0.52019615 |
| 113 | TYRO3 | 0.51795690 |
| 114 | PRKCZ | 0.51472000 |
| 115 | EPHA2 | 0.51143918 |
| 116 | MST1R | 0.51077244 |
| 117 | BMX | 0.50064718 |
| 118 | CAMK1D | 0.49721190 |
| 119 | PRKCG | 0.49348592 |
| 120 | CSNK1A1 | 0.49046066 |
| 121 | DAPK2 | 0.48410531 |
| 122 | STK11 | 0.47948250 |
| 123 | DYRK1A | 0.47490317 |
| 124 | PRKACG | 0.47132286 |
| 125 | PKN1 | 0.47074403 |
| 126 | ABL1 | 0.46745703 |
| 127 | PRKAA1 | 0.46447449 |
| 128 | EPHA4 | 0.46415079 |
| 129 | SGK223 | 0.46400256 |
| 130 | SGK494 | 0.46400256 |
| 131 | PINK1 | 0.43054578 |
| 132 | CASK | 0.42944526 |
| 133 | MAP2K7 | 0.42353069 |
| 134 | MAP3K7 | 0.42038862 |
| 135 | PRKG2 | 0.41091393 |
| 136 | PRKACA | 0.40215291 |
| 137 | PDGFRB | 0.39809759 |
| 138 | SGK1 | 0.36923026 |
| 139 | DMPK | 0.36504811 |
| 140 | RPS6KA3 | 0.34984377 |
| 141 | CDK9 | 0.34425846 |
| 142 | SGK3 | 0.34267480 |
| 143 | DDR2 | 0.34184044 |
| 144 | FES | 0.33699675 |
| 145 | BMPR1B | 0.33612296 |
| 146 | PRKCB | 0.32723302 |
| 147 | JAK1 | 0.32526119 |
| 148 | PDK1 | 0.32285714 |
| 149 | * PRKCA | 0.32148079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.77196408 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.29413402 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 3.21656764 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.92764538 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.76553051 |
| 6 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.66431425 |
| 7 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.62084580 |
| 8 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.51424335 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.40088677 |
| 10 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.32745378 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.14965226 |
| 12 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.13449925 |
| 13 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.07459072 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.00881401 |
| 15 | Cocaine addiction_Homo sapiens_hsa05030 | 1.97317953 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85602154 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.79195659 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.73601871 |
| 19 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.69639810 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.68140713 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.67011943 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.66409071 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.62708596 |
| 24 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.56935463 |
| 25 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.55047742 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.54765358 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53580102 |
| 28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.51115519 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.48722340 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47637861 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.46922615 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46436044 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.41869933 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.39463606 |
| 35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34685291 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.34252325 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33353936 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32756998 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31052957 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.30763960 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 1.30055788 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.29281093 |
| 43 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.27358602 |
| 44 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.24548432 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.20628528 |
| 46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.19437197 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 1.19002889 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18243835 |
| 49 | Nicotine addiction_Homo sapiens_hsa05033 | 1.17134909 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13883028 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10597714 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.08959426 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.07422235 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06188017 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.03741008 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03460843 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 1.03286504 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03202496 |
| 59 | Salivary secretion_Homo sapiens_hsa04970 | 1.03179980 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02627987 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02072770 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.99988462 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99409491 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97872065 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97436940 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96388289 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94870006 |
| 68 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91666986 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91416378 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.89715443 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88907816 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.88533323 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87820534 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85910989 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85906870 |
| 76 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.84522229 |
| 77 | Long-term depression_Homo sapiens_hsa04730 | 0.84448082 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84192450 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.81927432 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81483928 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.80995643 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.79771158 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78555159 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78266546 |
| 85 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77871335 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76257587 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75070284 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74438545 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72785528 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.71384785 |
| 91 | Axon guidance_Homo sapiens_hsa04360 | 0.70997853 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70081401 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66414954 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66048208 |
| 95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62971700 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62832167 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59863865 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58872339 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57734133 |
| 100 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57629308 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54278560 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53903828 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52512329 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52364969 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.51972767 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51545785 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50689123 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50517703 |
| 109 | Glioma_Homo sapiens_hsa05214 | 0.48557277 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47511325 |
| 111 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47414178 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47391040 |
| 113 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47244612 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.47121926 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46624793 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46583360 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45445091 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44633242 |
| 119 | Bile secretion_Homo sapiens_hsa04976 | 0.44585515 |
| 120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44352917 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43460151 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.43208011 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.43171401 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43153480 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.43005507 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42897823 |
| 127 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.42854461 |
| 128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42655208 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.42118183 |
| 130 | Adherens junction_Homo sapiens_hsa04520 | 0.42111345 |
| 131 | ABC transporters_Homo sapiens_hsa02010 | 0.41539905 |
| 132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39925794 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | 0.39849568 |
| 134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39619629 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39058856 |
| 136 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38653614 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38548819 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34764193 |
| 139 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34573246 |
| 140 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34457940 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31746167 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31074971 |
| 143 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30335039 |
| 144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30092796 |
| 145 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.29863741 |
| 146 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29832123 |
| 147 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28970376 |
| 148 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28457228 |
| 149 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28400935 |
| 150 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28270925 |

